Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005–2016

References

• AATOD (American Association for the Treatment of Opioid Dependence). ( 2006). Active OpioidTreatment Programs by State. Unpublished data acquired from SAMHSA, Center for Substance Abuse Treatment. www.aatod.org
   Google Scholar
• Banta-Green, C. J., Maynard, C., Koepsell, T. D., Wells, E. A., & Donovan, D. M. ( 2009). Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction, 104(5), 775–783. doi:10.1111/j.1360-0443.2009.02538.x
   PubMed Web of Science ®Google Scholar
• Berry, P. H., & Dahl, J. L. ( 2000). The new JCAHO pain standards: implications for pain management nurses. Pain Management Nursing, 1(1), 3–12. doi:10.1053/jpmn.2000.5833
   PubMedGoogle Scholar
• Broz, D., & Ouellet, L. J. ( 2008). Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug and Alcohol Dependence, 94(1-3), 221–233. doi:10.1016/j.drugalcdep.2007.11.020
   PubMed Web of Science ®Google Scholar
• Case, A., & Deaton, A. ( 2015). Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences of the United States of America, 112(49), 15078–15083. doi:10.1073/pnas.1518393112
   PubMed Web of Science ®Google Scholar
• Chen, J., Vargas-Bustamante, A., Mortensen, K., & Ortega, A. N. ( 2016). Racial and ethnic disparities in health care access and utilization under the affordable care act. Medical Care, 54(2), 140–146. doi:10.1097/MLR.0000000000000467
   PubMed Web of Science ®Google Scholar
• Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. ( 2014). The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826. doi:10.1001/jamapsychiatry.2014.366
   PubMed Web of Science ®Google Scholar
• Compton, W. M., Jones, C. M., & Baldwin, G. T. ( 2016). Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. New England Journal of Medicine, 374(2), 154–163. doi:10.1056/NEJMra1508490
   PubMed Web of Science ®Google Scholar
• Compton, W. M., & Volkow, N. D. ( 2006). Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend, 83(Suppl 1), S4–7. doi:10.1016/j.drugalcdep.2005.10.020
   PubMed Web of Science ®Google Scholar
• Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., … Taylor, R. S. ( 2007). Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment (Winchester, England), 11(9), 1–171, iii-iv.
   PubMed Web of Science ®Google Scholar
• Dart, R. C., Severtson, S. G., & Bucher-Bartelson, B. ( 2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(16), 1573–1574. doi:10.1056/NEJMc1501822
   PubMed Web of Science ®Google Scholar
• Dickason, R. M., Chauhan, V., Mor, A., Ibler, E., Kuehnle, S., Mahoney, D., … Dalawari, P. ( 2015). Racial differences in opiate administration for pain relief at an academic emergency department. The Western Journal of Emergency Medicine, 16(3), 372–380. doi:10.5811/westjem.2015.3.23893
   PubMed Web of Science ®Google Scholar
• Dole, V. P., & Nyswander, M. ( 1965). A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA, 193, 646–650.
   PubMed Web of Science ®Google Scholar
• Dunlap, E., Golub, A., & Johnson, B. D. ( 2006). The severely-distressed African American family in the crack era: Empowerment is not enough. Journal of Sociology and Social Welfare, 33(1), 115–139.
   PubMedGoogle Scholar
• Frenk, S. M., Porter, K. S., & Paulozzi, L. J. ( 2015). Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief 189, 1–8.
   Google Scholar
• Furst, R. T., Herrmann, C., Leung, R., Galea, J., & Hunt, K. ( 2004). Heroin diffusion in the mid-Hudson region of New York State. Addiction, 99(4), 431–441. doi:10.1111/j.1360-0443.2003.00673.x
   PubMed Web of Science ®Google Scholar
• Gerra, G., Maremmani, I., Capovani, B., Somaini, L., Berterame, S., Tomas-Rossello, J., … Kleber, H. ( 2009). Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them “substitution”? Substance use & misuse, 44(5), 663–671. doi:10.1080/10826080902810251
   PubMed Web of Science ®Google Scholar
• Golub, A. L., & Johnson, B. D. ( 1999). Cohort changes in illegal drug use among arrestees in Manhattan: From the Heroin Injection Generation to the Blunts Generation. Substance use & misuse, 34(13), 1733–1763.
   PubMed Web of Science ®Google Scholar
• Goyal, M. K., Kuppermann, N., Cleary, S. D., Teach, S. J., & Chamberlain, J. M. ( 2015). Racial disparities in pain management of children with appendicitis in emergency departments. JAMA Pediatrics, 169(11), 996–1002. doi:10.1001/jamapediatrics.2015.1915
   PubMed Web of Science ®Google Scholar
• Havens, J. R., Oser, C. B., Leukefeld, C. G., Webster, J. M., Martin, S. S., O'Connell, D. J., … Inciardi, J. A. ( 2007). Differences in prevalence of prescription opiate misuse among rural and urban probationers. American Journal of Drug and Alcohol Abuse, 33(2), 309–317. doi:10.1080/00952990601175078
   PubMed Web of Science ®Google Scholar
• Havens, J. R., Walker, R., & Leukefeld, C. G. ( 2008). Prescription opioid use in the rural Appalachia: a community-based study. Journal of Opioid Management, 4(2), 63–71.
   PubMedGoogle Scholar
• Hoffman, K. M., Trawalter, S., Axt, J. R., & Oliver, M. N. ( 2016). Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proceedings of the National Academy of Sciences of the United States of America, 113(16), 4296–4301. doi:10.1073/pnas.1516047113
   PubMed Web of Science ®Google Scholar
• Institute of Medicine Committee on Federal Regulation of Methadone, T. ( 1995). In R. A. Rettig, & A. Yarmolinsky (Eds.), Federal Regulation of Methadone Treatment. Washington (DC): National Academies Press (US).
   Google Scholar
• Jaffe, J. H., & O'Keeffe, C. ( 2003). From morphine clinics to buprenorphine: Regulating opioid agonist treatment of addiction in the United States. Drug and Alcohol Dependence, 70(2 Suppl), S3–11.
   PubMedGoogle Scholar
• Johnson, B., & Golub, A. ( 2002). Generational trends in heroin use and injection in New York City. In D. F. Musto (Ed.), One Hundred Years of Heroin (pp. 92–128). Westport, CT: Auburn House of Greenwood Publishing Group, Inc.
   Google Scholar
• Jones, C. M., Logan, J., Gladden, R. M., & Bohm, M. K. ( 2015). Vital signs: Demographic and substance use trends among Heroin users - United States, 2002-2013. MMWR Morbidity and Mortality Weekly Report, 64(26), 719–725.
   PubMed Web of Science ®Google Scholar
• Joseph, H., Stancliff, S., & Langrod, J. ( 2000). Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mount Sinai Journal of Medicine, 67(5-6), 347–364.
   PubMedGoogle Scholar
• Kleber, H. D. ( 2008). Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. JAMA: The Journal of the American Medical Association, 300(19), 2303–2305. doi:10.1001/jama.2008.648
   PubMed Web of Science ®Google Scholar
• Lozier, M. J., Boyd, M., Stanley, C., Ogilvie, L., King, E., Martin, C., & Lewis, L. ( 2015). Acetyl Fentanyl, a novel fentanyl analog, causes 14 overdose deaths in Rhode island, March-May 2013. Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology, 11(2), 208–217.
   PubMedGoogle Scholar
• Magura, S., & Rosenblum, A. ( 2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine, 68(1), 62–74.
   PubMedGoogle Scholar
• Martins, S. S., Santaella-Tenorio, J., Marshall, B. D., Maldonado, A., & Cerda, M. ( 2015). Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users. Drug Alcohol Depend, 151, 278–283. doi:10.1016/j.drugalcdep.2015.03.020
   PubMed Web of Science ®Google Scholar
• Martins, S. S., Segura, L. E., Santaella-Tenorio, J., Perlmutter, A., Fenton, M. C., Cerdá, M., … Hasin, D. S. ( 2017). Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. Addictive Behaviors, 65, 236–241. doi: https://doi.org/10.1016/j.addbeh.2016.08.033
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. ( 2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews (Online) (3), CD002209. doi:10.1002/14651858.CD002209.pub2
   Web of Science ®Google Scholar
• Maxwell, J. C. ( 2011). The prescription drug epidemic in the United States: A perfect storm. Drug and Alcohol Review, 30(3), 264–270. doi:10.1111/j.1465-3362.2011.00291.x
   PubMed Web of Science ®Google Scholar
• McCabe, B. E., Santisteban, D. A., Mena, M. P., Duchene, D. M., McLean, C., & Monroe, M. ( 2013). Engagement, retention, and abstinence for three types of opioid users in Florida. Substance use & misuse, 48(8), 623–634. doi:10.3109/10826084.2013.800112
   PubMed Web of Science ®Google Scholar
• Meghani, S. H., Byun, E., & Gallagher, R. M. ( 2012). Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Medicine (Malden, Mass), 13(2), 150–174. doi:10.1111/j.1526-4637.2011.01310.x
   Google Scholar
• Monwell, B., Bulow, P., & Gerdner, A. ( 2016). Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems? Substance Abuse Treatment, Prevention, and Policy, 11(1), 23. doi:10.1186/s13011-016-0066-1
   PubMed Web of Science ®Google Scholar
• Morrison, R. S., Wallenstein, S., Natale, D. K., Senzel, R. S., & Huang, L. L. ( 2000). “We don't carry that”–failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. New England Journal of Medicine, 342(14), 1023–1026. doi:10.1056/nejm200004063421406
   PubMed Web of Science ®Google Scholar
• Palamar, J. J., Shearston, J. A., Dawson, E. W., Mateu-Gelabert, P., & Ompad, D. C. ( 2016). Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug Alcohol Depend, 158, 132–138. doi:10.1016/j.drugalcdep.2015.11.005
   PubMed Web of Science ®Google Scholar
• Patten, E. ( 2015). Who is multiracial? Depends on how you ask. A Comparison of six survey methods to capture racial identity. Retrieved from Washington, D.C.: http://www.pewsocialtrends.org/files/2015/11/2015-11-06_race-question-methods_FINAL.pdf
   Google Scholar
• Pletcher, M. J., Kertesz, S. G., Kohn, M. A., & Gonzales, R. ( 2008). Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA: The Journal of the American Medical Association, 299(1), 70–78. doi:10.1001/jama.2007.64
   PubMed Web of Science ®Google Scholar
• Potter, J. S., Marino, E. N., Hillhouse, M. P., Nielsen, S., Wiest, K., Canamar, C. P., … Ling, W. ( 2013). Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). Journal of Studies on Alcohol and Drugs, 74(4), 605–613.
   PubMed Web of Science ®Google Scholar
• Prangnell, A., Daly-Grafstein, B., Dong, H., Nolan, S., Milloy, M., Wood, E., … Hayashi, K. ( 2016). Factors associated with inability to access addiction treatment among people who inject drugs in Vancouver, Canada. Substance Abuse Treatment, Prevention, and Policy, 11, 9.
   PubMed Web of Science ®Google Scholar
• Qian, H. Z., Hao, C., Ruan, Y., Cassell, H. M., Chen, K., Qin, G., … Shao, Y. ( 2008). Impact of methadone on drug use and risky sex in China. Journal of Substance Abuse Treatment, 34(4), 391–397. doi:10.1016/j.jsat.2007.07.002
   PubMed Web of Science ®Google Scholar
• Rosenblum, A., Cleland, C. M., Fong, C., Kayman, D. J., Tempalski, B., & Parrino, M. ( 2011). Distance traveled and cross-state commuting to opioid treatment programs in the United States. J Environ Public Health, 2011, 948789. doi:10.1155/2011/948789
   PubMedGoogle Scholar
• Rothman, K. J., Greenland, S., & Lash, T. L. ( 2008). Modern Epidemiology (3rd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.
   Google Scholar
• Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. ( 2016a). Increases in drug and opioid overdose deaths–United States, 2000-2014. MMWR Morbidity and Mortality Weekly Report, 64(50-51), 1378–1382. doi:10.15585/mmwr.mm6450a3
   PubMed Web of Science ®Google Scholar
• Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. ( 2016b). Increases in drug and opioid overdose deaths - United States, 2000-2014. MMWR Morbidity and Mortality Weekly Report, 64(50-51), 1378–1382. doi:10.15585/mmwr.mm6450a3
   PubMed Web of Science ®Google Scholar
• Rudd, R. A., Paulozzi, L. J., Bauer, M. J., Burleson, R. W., Carlson, R. E., Dao, D., … Prevention. ( 2014). Increases in heroin overdose deaths - 28 States, 2010 to 2012. MMWR Morbidity and Mortality Weekly Report, 63(39), 849–854.
   PubMed Web of Science ®Google Scholar
• Rudd, R. A., Seth, P., David, F., & Scholl, L. ( 2016). Increases in drug and opioid-involved overdose deaths–United States, 2010-2015. MMWR Morbidity and Mortality Weekly Report, 65( ePub: 16 December). 65(50–51), 1445–1452. doi: https://doi.org/10.15585/mmwr.mm655051e1
   PubMed Web of Science ®Google Scholar
• Saloner, B., Stoller, K. B., & Barry, C. L. ( 2016). Medicaid coverage for methadone maintenance and use of opioid agonist therapy in specialty addiction treatment. Psychiatric Services, 67(6), 676–679. doi:10.1176/appi.ps.201500228
   PubMed Web of Science ®Google Scholar
• SAMHSA. ( 2016). National Survey on Drug Use and Health. Retrieved from https://nsduhweb.rti.org/respweb/project_description.html
   Google Scholar
• SAMHSA; Office of Applied Studies. ( 2004). Treatment Admissions Involving Narcotic Pain Killers: 2002 Update. Retrieved from http://www.oas.samhsa.gov/2k4/painTX/painTX.htm
   Google Scholar
• Singhal, A., Tien, Y. Y., & Hsia, R. Y. ( 2016). Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PLoS One, 11(8), e0159224. doi:10.1371/journal.pone.0159224
   PubMed Web of Science ®Google Scholar
• Stogner, J. M. ( 2014). The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl “disguised” as other opioids. Annals of Emergency Medicine, 64(6), 637–639.
   PubMed Web of Science ®Google Scholar
• Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. ( 1999). Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA: The Journal of the American Medical Association, 281(11), 1000–1005.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, & Division of Pharmacologic Therapies. ( 2017). Medication-Assisted Treatment for Substance Use Disorders: Opioid Treatment Program Directory. Retrieved from http://dpt2.samhsa.gov/treatment/
   Google Scholar
• U.S. Census Bureau, P. D. ( 2006). Geographic Terms and Definitions. Retrieved from http://www.census.gov/popest/geographic/
   Google Scholar
• US Census Bureau. ( 2011a). The Black Population: 2010. Retrieved from http://www.census.gov/prod/cen2010/briefs/c2010br-06.pdf.
   Google Scholar
• US Census Bureau. ( 2011b). The Hispanic Population: 2010. Retrieved from http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.
   Google Scholar
• USDA. Economic Research Service. ( 2003). Rural–urban continuums for 2003. Retrieved from http://www.ers.usda.gov/data/RuralUrbanContinuumCodes.
   Google Scholar
• Vaughn, M. G., Nelson, E. J., Salas-Wright, C. P., Qian, Z., & Schootman, M. ( 2016). Racial and ethnic trends and correlates of non-medical use of prescription opioids among adolescents in the United States 2004-2013. Journal of Psychiatric Research, 73, 17–24. doi:10.1016/j.jpsychires.2015.11.003
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., … Ling, W. ( 2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Archives of General Psychiatry, 68(12), 1238–1246. doi:10.1001/archgenpsychiatry.2011.121
   PubMedGoogle Scholar
• Weiss, R. D., Potter, J. S., Griffin, M. L., Provost, S. E., Fitzmaurice, G. M., McDermott, K. A., … Carroll, K. M. ( 2015). Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend, 150, 112–119. doi:10.1016/j.drugalcdep.2015.02.030
   PubMed Web of Science ®Google Scholar
• Wu, L. T., Woody, G. E., Yang, C., & Blazer, D. G. ( 2011). How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Addiction Medicine, 5(1), 28–35. doi:10.1097/ADM.0b013e3181e0364e
   PubMed Web of Science ®Google Scholar
• Yin, W., Hao, Y., Sun, X., Gong, X., Li, F., Li, J., … Wu, Z. ( 2010). Scaling up the national methadone maintenance treatment program in China: Achievements and challenges. International Journal of Epidemiology, 39(Suppl 2), ii29–37. doi:10.1093/ije/dyq210
   PubMed Web of Science ®Google Scholar